×

MEDTECH Honored by Frost & Sullivan With "Excellence in Best Practices" Award

MONTPELLIER, France, Nov. 6, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing surgical robots, has been awarded the "Excellence in Best Practices" prize at Frost & Sullivan's Company of the Year Awards ceremony. This is the second time Medtech has been commended by the strategic consulting company, Frost & Sullivan.

Medtech was recognized for its achievements in the field of minimally invasive neurosurgery. The award was based on Medtech's recent analysis of the global market for surgical robotic devices applied to neurosurgery.

ROSA's revolutionary technology is already widely recognized and has led to an increase in patient safety by assisting surgeons during their interventions, making the surgical act more reliable and improving the performance of health systems.

Frost & Sullivan also emphasize Medtech's development strategy. In just 10 years, the company has become a key international player in the field of surgical robotics for the central nervous system. In addition, Medtech recorded a 158% increase in revenue in 2015, with 48 ROSA™ robots worldwide, including 15 in Europe, 21 in North America and 12 in other parts of the world.

Medtech was already honored by Frost & Sullivan in the "robotic neurosurgery" category at the 2013 European Company of the Year Awards.

Next venues and investors' meetings
-- Stifel 2015 Healthcare Conference, New York November 17-18, 2015
-- Jefferies Autumn 2015 Global Healthcare Conference, London November 18-19, 2015
-- Natixis Midcap Conference, Paris November 24, 2015
-- Oddo Midcap Conference, Lyon January 7-8, 2016

About MEDTECH

Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013, MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.

In 2015 MEDTECH received the "2016 Company of the Year Award" in the " robotic neurosurgery" category from Frost & Sullivan.

CONTACT: MEDTECH Christophe Sibillin Chief Financial Officer Tel : +33 (0)4 67 10 77 40 INVESTORS Corinne Puissant Tel : +33 (0)1 53 67 36 77 cpuissant@actus.fr PRESS Alexandra Prisa (EU) Tel. : +33(0)1 53 67 36 90 aprisa@actus.fr Joanna Zimmerman (US) Tel : +1 646-536-7006 jzimmerman@theruthgroup.com

Source:Medtech SA

More From Press Releases